Single-dose pharmacokinetics of indinavir and the effect of food. (Q39556676)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527781 AND SRC:MED&resulttype=core&format=json

10 November 2019

title

Single-dose pharmacokinetics of indinavir and the effect of food (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527781 AND SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

1 reference

K C Yeh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527781 AND SRC:MED&resulttype=core&format=json

10 November 2019

P J Deutsch

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527781 AND SRC:MED&resulttype=core&format=json

10 November 2019

H Haddix

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527781 AND SRC:MED&resulttype=core&format=json

10 November 2019

M Hesney

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527781 AND SRC:MED&resulttype=core&format=json

10 November 2019

V Hoagland

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527781 AND SRC:MED&resulttype=core&format=json

10 November 2019

W D Ju

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527781 AND SRC:MED&resulttype=core&format=json

10 November 2019

S J Justice

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527781 AND SRC:MED&resulttype=core&format=json

10 November 2019

B Osborne

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527781 AND SRC:MED&resulttype=core&format=json

10 November 2019

A T Sterrett

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527781 AND SRC:MED&resulttype=core&format=json

10 November 2019

J A Stone

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527781 AND SRC:MED&resulttype=core&format=json

10 November 2019

E Woolf

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527781 AND SRC:MED&resulttype=core&format=json

10 November 2019

S Waldman

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527781 AND SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

English

0 references

publication date

1 February 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527781 AND SRC:MED&resulttype=core&format=json

Antimicrobial Agents and Chemotherapy

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527781 AND SRC:MED&resulttype=core&format=json

10 November 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527781 AND SRC:MED&resulttype=core&format=json

10 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527781 AND SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

332-338

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527781 AND SRC:MED&resulttype=core&format=json

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

10 November 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105409

L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105409

The effects of food on drug bioavailability

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105409

Effects of food on drug absorption

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105409

Rational design of peptide-based HIV proteinase inhibitors

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105409

HIV protease: a novel chemotherapeutic target for AIDS.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105409

The HIV-1 protease as a therapeutic target for AIDS

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105409

Significant drug-nutrient interactions

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105409

Crystalluria and urinary tract abnormalities associated with indinavir

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105409

Urinary stones in HIV-1-positive patients treated with indinavir

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105409

Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105409

pH-dependent oral absorption of L-735,524, a potent HIV protease inhibitor, in rats and dogs

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105409

Pharmacokinetic evaluation of stable piecewise cubic polynomials as numerical integration functions.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105409

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105409

Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105409

A 24-week open-label phase I/II evaluation of the HIV protease inhibitor MK-639 (indinavir).

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105409

Determination of L-735 524, an human immunodeficiency virus protease inhibitor, in human plasma and urine via high-performance liquid chromatography with column switching

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105409

Metabolites of L-735,524, a potent HIV-1 protease inhibitor, in human urine

21 August 2018

1 reference

12 December 2020

Regiospecific intestinal absorption of the HIV protease inhibitor L-735,524 in beagle dogs

1 reference

12 December 2020

Drug-nutrient interactions

1 reference

12 December 2020

Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans

1 reference

12 December 2020

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9527781 AND SRC:MED&resulttype=core&format=json

10 November 2019

PubMed publication ID

9527781

1 reference